100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
Abiraterone-5,6-Epoxide
● Under Development
| Catalogue No.: | VL830013 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C24H31NO2 |
| Mol. Weight: | 365.52 g/mol |
Additional information on Abiraterone-5 | 6-Epoxide
Parent drug
AbirateroneIUPAC Name
(3S, 6aS, 6bS, 9aS, 11aS, 11bR)-9a, 11b-dimethyl-9-(pyridin-3-yl)-1, 2, 3, 4, 5a, 6, 6a, 6b, 7, 9a, 10, 11, 11a, 11b-tetradecahydrocyclopenta[1, 2]phenanthro[8a, 9-b]oxiren-3-olPharmacopoeial Synonyms
N/ASmiles
O[C@H](C1)CC[C@]2(C)[C@@]3([H])CC[C@@](C(C4=CC=CN=C4)=CC5)(C)[C@]5([H])[C@]3([H])CC6C21O6Description
Abiraterone-5,6-Epoxide or (3S,6aS,6bS,9aS,11aS,11bR)-9a,11b-dimethyl-9-(pyridin-3-yl)-1,2,3,4,5a,6,6a,6b,7,9a,10,11,11a,11b-tetradecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-3-ol, is an antiandrogen class and it is a used in the treatment a certain type of prostate cancer.
References
Goldberg, Tamara, and Evangelina Berrios-Colon. “Abiraterone (Zytiga), a Novel Agent for the Management of Castration-Resistant Prostate Cancer.” Pharmacy and Therapeutics, vol. 38, no. 1, 1 Jan. 2013, pp. 23–26, www.ncbi.nlm.nih.gov/pmc/articles/PMC3628169/.InChI
InChI=1S/C24H31NO2/c1-22-9-8-20-17(19(22)6-5-18(22)15-4-3-11-25-14-15)12-21-24(27-21)13-16(26)7-10-23(20,24)2/h3-5,11,14,16-17,19-21,26H,6-10,12-13H2,1-2H3/t16-,17-,19-,20-,21?,22+,23+,24?/m0/s1Request a Quote
"*" indicates required fields
Other products related to Abiraterone impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
